Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The presentations underscore the company’s deep expertise in dermatology and immunology
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments
Subscribe To Our Newsletter & Stay Updated
